NCT01868451 2025-07-09
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital